230 related articles for article (PubMed ID: 18800755)
1. [Role of octreotide in the treatment of hypoglycemia induced by sulfonylureas].
Clerc D; Hugli O; Trueb L; Yersin B
Rev Med Suisse; 2008 Aug; 4(167):1764-7. PubMed ID: 18800755
[TBL] [Abstract][Full Text] [Related]
2. Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia.
Fasano CJ; O'Malley G; Dominici P; Aguilera E; Latta DR
Ann Emerg Med; 2008 Apr; 51(4):400-6. PubMed ID: 17764782
[TBL] [Abstract][Full Text] [Related]
3. Safety of subcutaneous octreotide in patients with sulfonylurea-induced hypoglycemia and congestive heart failure.
Vallurupalli S
Ann Pharmacother; 2010 Feb; 44(2):387-90. PubMed ID: 20118140
[TBL] [Abstract][Full Text] [Related]
4. Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia.
Francis M; Langhan T; Prosser J; Hoffman R
Ann Emerg Med; 2008 Jun; 51(6):795-6; author reply 796-7. PubMed ID: 18489980
[No Abstract] [Full Text] [Related]
5. [Successful treatment of severe sulfonylurea-induced hypoglycemia by the subcutaneous administration of octreotide in an elderly patient with diabetes: A case report].
Nakaya M; Oka R; Miyamoto S
Nihon Ronen Igakkai Zasshi; 2019; 56(3):336-342. PubMed ID: 31366755
[TBL] [Abstract][Full Text] [Related]
6. Octreotide for hypoglycemia caused by sulfonylurea and DPP-4 inhibitor.
Yamaguchi S; Ikejima M; Furukawa A; Abe M; Nakazaki M; Ishihara H
Diabetes Res Clin Pract; 2015 Aug; 109(2):e8-e10. PubMed ID: 26025695
[TBL] [Abstract][Full Text] [Related]
7. The E23K variant of KCNJ11 and the risk for severe sulfonylurea-induced hypoglycemia in patients with type 2 diabetes.
Holstein A; Hahn M; Stumvoll M; Kovacs P
Horm Metab Res; 2009 May; 41(5):387-90. PubMed ID: 19214942
[TBL] [Abstract][Full Text] [Related]
8. Octreotide in children with hypoglycaemia due to sulfonylurea ingestion.
Rath S; Bar-Zeev N; Anderson K; Fahy R; Roseby R
J Paediatr Child Health; 2008 Jun; 44(6):383-4. PubMed ID: 18476935
[TBL] [Abstract][Full Text] [Related]
9. [The relatively frequent incidence of severe sulfonylurea-induced hypoglycemia in the last 25 years in Switzerland. Results of 2 surveys in Switzerland in 1969 and 1984].
Berger W; Caduff F; Pasquel M; Rump A
Schweiz Med Wochenschr; 1986 Feb; 116(5):145-51. PubMed ID: 3961464
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of sulfonylurea-induced prolonged hypoglycemia with use of octreotide.
Fleseriu M; Skugor M; Chinnappa P; Siraj ES
Endocr Pract; 2006; 12(6):635-40. PubMed ID: 17229659
[TBL] [Abstract][Full Text] [Related]
11. Octreotide: an antidote for sulfonylurea-induced hypoglycemia.
McLaughlin SA; Crandall CS; McKinney PE
Ann Emerg Med; 2000 Aug; 36(2):133-138. PubMed ID: 10918104
[TBL] [Abstract][Full Text] [Related]
12. Recurrent sulfonylurea induced nocturnal hypoglycemia managed with tolbutamide.
Borst GC
J Ky Med Assoc; 1988 Mar; 86(3):129-30. PubMed ID: 3356924
[No Abstract] [Full Text] [Related]
13. Sulfonylurea-induced hypoglycaemia: use of octreotide.
Hanchard B; Boulouffe C; Vanpee D
Acta Clin Belg; 2009; 64(1):56-8. PubMed ID: 19317242
[TBL] [Abstract][Full Text] [Related]
14. Octreotide treatment for sulfonylurea-induced hypoglycaemia.
Crawford BA; Perera C
Med J Aust; 2004 May; 180(10):540-1; author reply 541. PubMed ID: 15139835
[No Abstract] [Full Text] [Related]
15. Octreotide for the treatment of sulfonylurea poisoning.
Glatstein M; Scolnik D; Bentur Y
Clin Toxicol (Phila); 2012 Nov; 50(9):795-804. PubMed ID: 23046209
[TBL] [Abstract][Full Text] [Related]
16. Octreotide for sulfonylurea-induced hypoglycemia following overdose.
Carr R; Zed PJ
Ann Pharmacother; 2002 Nov; 36(11):1727-32. PubMed ID: 12398568
[TBL] [Abstract][Full Text] [Related]
17. Octreotide therapy for nateglinide-induced hypoglycemia.
Sherk DK; Bryant SM
Ann Emerg Med; 2007 Dec; 50(6):745-6. PubMed ID: 18023765
[No Abstract] [Full Text] [Related]
18. Octreotide: a novel therapy for refractory sulfonylurea-induced hypoglycemia.
Barkin JA; Block HM; Mendez PE
Pancreas; 2013 May; 42(4):722-3. PubMed ID: 23591434
[No Abstract] [Full Text] [Related]
19. Evaluation of the use and safety of octreotide as antidotal therapy for sulfonylurea overdose in children.
Dougherty PP; Lee SC; Lung D; Klein-Schwartz W
Pediatr Emerg Care; 2013 Mar; 29(3):292-5. PubMed ID: 23426239
[TBL] [Abstract][Full Text] [Related]
20. Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide.
Lheureux PE; Zahir S; Penaloza A; Gris M
Crit Care; 2005; 9(6):543-9. PubMed ID: 16356235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
